Xponance Inc. purchased a new stake in shares of American Healthcare REIT, Inc. (NYSE:AHR – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 11,019 shares of the company’s stock, valued at approximately $313,000.
A number of other hedge funds have also bought and sold shares of AHR. GAMMA Investing LLC raised its stake in shares of American Healthcare REIT by 104.1% during the 4th quarter. GAMMA Investing LLC now owns 988 shares of the company’s stock worth $28,000 after purchasing an additional 504 shares during the period. Richardson Capital Management LLC purchased a new stake in American Healthcare REIT during the fourth quarter worth about $29,000. Carolina Wealth Advisors LLC bought a new stake in American Healthcare REIT in the fourth quarter worth about $29,000. Wilmington Savings Fund Society FSB bought a new stake in American Healthcare REIT in the third quarter worth about $28,000. Finally, Quarry LP purchased a new position in American Healthcare REIT in the third quarter valued at about $33,000. 16.68% of the stock is currently owned by institutional investors.
American Healthcare REIT Stock Up 0.4 %
Shares of NYSE AHR opened at $29.95 on Friday. American Healthcare REIT, Inc. has a 52 week low of $12.81 and a 52 week high of $30.97. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. The company has a market cap of $4.72 billion and a P/E ratio of -62.39. The business has a 50-day simple moving average of $28.94 and a two-hundred day simple moving average of $27.50.
American Healthcare REIT Dividend Announcement
Wall Street Analyst Weigh In
AHR has been the topic of a number of research reports. JMP Securities set a $35.00 price target on shares of American Healthcare REIT in a report on Tuesday, March 4th. Morgan Stanley boosted their target price on American Healthcare REIT from $36.00 to $37.00 and gave the company an “overweight” rating in a research note on Tuesday. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price target on shares of American Healthcare REIT in a research note on Wednesday, March 19th. Finally, Citigroup restated an “outperform” rating on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $32.17.
Get Our Latest Analysis on American Healthcare REIT
About American Healthcare REIT
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.
Featured Articles
- Five stocks we like better than American Healthcare REIT
- Want to Profit on the Downtrend? Downtrends, Explained.
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellÂ
- 3 REITs to Buy and Hold for the Long Term
- Top 3 Beverage Stocks Pouring Out Profits
- 3 Fintech Stocks With Good 2021 Prospects
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding AHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Healthcare REIT, Inc. (NYSE:AHR – Free Report).
Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.